Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial

Kerry S Courneya, Robert D Reid, Christine M Friedenreich, Karen Gelmon, Caroline Proulx, Jeffrey K Vallance, Donald C McKenzie, Roanne J Segal, Kerry S Courneya, Robert D Reid, Christine M Friedenreich, Karen Gelmon, Caroline Proulx, Jeffrey K Vallance, Donald C McKenzie, Roanne J Segal

Abstract

Background: Patient preference for group assignment may affect outcomes in unblinded trials but few studies have attempted to understand such preferences. The purpose of the present study was to examine factors associated with breast cancer patients' preference for two types of exercise training during chemotherapy.

Methods: Breast cancer patients (N = 242) completed a battery of tests including a questionnaire that assessed patient preference and the theory of planned behavior (TPB) prior to being randomized to usual care, resistance exercise training (RET), or aerobic exercise training (AET).

Results: 99 (40.9%) participants preferred RET, 88 (36.4%) preferred AET, and 55 (22.7%) reported no preference. Past exercisers (p = 0.023), smokers (p = 0.004), and aerobically fitter participants (p = 0.005) were more likely to prefer RET. As hypothesized, participants that preferred AET had more favorable TPB beliefs about AET whereas participants that preferred RET had more favorable TPB beliefs about RET. In multivariate modeling, patient preference for RET versus AET was explained (R2 = .46; p < 0.001) by the difference in motivation for RET versus AET (beta = .56; p < 0.001), smoking status (beta = .13; p = 0.007), and aerobic fitness (beta = .12; p = 0.018). Motivational difference between RET versus AET, in turn, was explained (R2 = .48; p < 0.001) by differences in instrumental attitude (beta = .27; p < 0.001), affective attitude (beta = .25; p < 0.001), and perceived behavioral control (beta = .24; p < 0.001).

Conclusion: Breast cancer patients' preference for RET versus AET during chemotherapy was predicted largely by a difference in motivation for each type of exercise which, in turn, was based on differences in their beliefs about the anticipated benefits, enjoyment, and difficulty of performing each type of exercise during chemotherapy. These findings may help explain patient preference effects in unblinded behavioral trials.

Trial registration: ClinicalTrials.gov Identifier NCT00115713.

Figures

Figure 1
Figure 1
Motivation for aerobic versus resistance exercise by patient preference. Note: AET = aerobic exercise training; RET = resistance exercise training. Motivation assessed on a 7 point scale from 1 to 7.
Figure 2
Figure 2
Association between recent exercise and patient preference. AET = aerobic exercise training; RET = resistance exercise training. Note: Exercisers defined as performing at least 150 minutes of moderate-to-vigorous exercise/week or 60 minutes of vigorous exercise/week.
Figure 3
Figure 3
Association between smoking and patient preference. Note: AET = aerobic exercise training; RET = resistance exercise training.
Figure 4
Figure 4
Association between baseline aerobic fitness and patient preference. Note: AET = aerobic exercise training; RET = resistance exercise training.

References

    1. Moher D, Schulz KF, Altman D. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials. Explore (NY) 2005;1:40–45.
    1. Davidson KW, Goldstein M, Kaplan RM, et al. Evidence-based behavioral medicine: what is it and how do we achieve it? Annals of Behavioral Medicine. 2003;26:161–171. doi: 10.1207/S15324796ABM2603_01.
    1. Torgerson DJ, Sibbald B. Understanding controlled trials. What is a patient preference trial? BMJ. 1998;316:360.
    1. Bower P, King M, Nazareth I, et al. Patient preferences in randomised controlled trials: conceptual framework and implications for research. Social Science & Medicine. 2005;61:685–695. doi: 10.1016/j.socscimed.2004.12.010.
    1. Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. J Clin Oncol. 2007;25:4396–4404. doi: 10.1200/JCO.2006.08.2024.
    1. Courneya KS, Segal RJ, Gelmon K, et al. Six-month follow-up of patient-rated outcomes in a randomized controlled trial of exercise training during breast cancer chemotherapy. Cancer Epidemiol Biomarkers Prev. 2007;16:2572–2578. doi: 10.1158/1055-9965.EPI-07-0413.
    1. Courneya KS, Segal RJ, Gelmon K, et al. Moderators of the Effects of Exercise Training in Breast Cancer Patient Receiving Chemotherapy. A randomized controlled trial. Cancer. 2008;112:1845–1853. doi: 10.1002/cncr.23379.
    1. Courneya KS, Segal RJ, Gelmon K, et al. Barriers to Supervised Exercise Training in a Randomized Controlled Trial of Breast Cancer Patients Receiving Chemotherapy. Ann Behav Med. 2008;35:116–122.
    1. Courneya KS, Segal RJ, Gelmon K, et al. Predictors of supervised exercise adherence during breast cancer chemotherapy. Med Sci Sports Exerc. 2008;40:1180–1187. doi: 10.1249/MSS.0b013e318168da45.
    1. Courneya KS, Segal RJ, Gelmon K, et al. Predictors of Follow-Up Exercise Behavior Six Months After a Randomized Trial of Exercise Training During Breast Cancer Chemotherapy. Breast Cancer Res Treat. 2008, Apr 4.
    1. Ajzen I. The theory of planned behavior. Organizational Behavior & Human Decision Processes. 1991;50:179–211. doi: 10.1016/0749-5978(91)90020-T.
    1. Icek Ajzen Web site [Internet]. Theory of Planned Behavior. Constructing a TpB Questionnaire
    1. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10:141–146.
    1. Haskell WL, Lee I, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the american college of sports medicine and the american heart association. Med Sci Sports Exerc. 2007;39:1423–1434. doi: 10.1249/mss.0b013e3180616b27.
    1. Cella D, Eton DT, Lai JS, et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24:547–561. doi: 10.1016/S0885-3924(02)00529-8.
    1. Rosenberg M. Society and the adolescent self-image. Princeton, NJ: Princeton University Press; 1965.
    1. Radloff L. The use of the center for epidemiologic studies depression scale in adolescents and young adults. J Adolesc. 1991;20:149–166.
    1. Spielberger C, Gorusch R, Lushene R. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
    1. McPherson K, Chalmers I. Incorporating patient preferences into clinical trials. Information about patients' preference must be obtained first. BMJ. 1998;317:78.

Source: PubMed

3
Subscribe